Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma

Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma

Abstract Background For patients with multiple myeloma (MM), each additional line of therapy (LOT) is associated with lower response rates, shorter treatment duration and treatment-free intervals, and increased rates of toxicities and comorbidities. Here, we examine frontline treatment patterns, and...

Full description

Bibliographic Details
Main Authors: Rafael Fonseca, Saad Z. Usmani, Maneesha Mehra, Mary Slavcev, Jianming He, Sarah Cote, Annette Lam, Jon Ukropec, Eric M. Maiese, Sandhya Nair, Ravi Potluri, Peter M. Voorhees
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Cancer
Subjects:
Attrition rates
Autologous stem cell transplant
Bortezomib
Dexamethasone
Lenalidomide
Line of therapy
Online Access:http://link.springer.com/article/10.1186/s12885-020-07503-y

Similar Items

Similar Items